Inventor · disambiguated record
Ming Qi
Also filed as: QI MING
25 granted patents·28 pending applications·451 citations·filing 1999–2023
96Inventor score
Files withJANSSEN BIOTECH INC18PROCTER & GAMBLE10FIRMENICH INCORPORATED3SENOMYX INC3TACHDJIAN CATHERINE3
Top patents by PatentIndex Score
53 records- 0199US7476399B2Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereofSENOMYX INC·Filed 2004·Granted Jan 13, 2009·94 cites·19 claims
- 0297US8124121B2Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereofTACHDJIAN CATHERINE·Filed 2008·Granted Feb 28, 2012·93 cites·7 claims
- 0396US8524709B2Kinase inhibitor compoundsLIANG CONGXIN·Filed 2012·Granted Sep 3, 2013·42 cites·17 claims
- 0495US8895050B2Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereofTACHDJIAN CATHERINE·Filed 2011·Granted Nov 25, 2014·12 cites·16 claims
- 0592US8831440B2Method and device for generating optical signalsYU DEZHONG·Filed 2010·Granted Sep 9, 2014·95 cites·15 claims
- 0691US11618787B2Methods of treating high risk multiple myelomaJANSSEN BIOTECH INC·Filed 2018·Granted Apr 4, 2023·10 cites·12 claims
- 0790USD880293SOral care package with surface ornamentationPROCTER & GAMBLE·Filed 2018·Granted Apr 7, 2020·34 cites·1 claims
- 0889US6768024B1Triamine derivative melanocortin receptor ligands and methods of using sameLION BIOSCIENCE AG·Filed 2000·Granted Jul 27, 2004·28 cites·19 claims
- 0988US8039470B2Kinase inhibitor compoundsTYROGENEX INC·Filed 2010·Granted Oct 18, 2011·12 cites·5 claims
- 1087USD928607SOral care package with surface ornamentationPROCTER & GAMBLE·Filed 2020·Granted Aug 24, 2021·12 cites·1 claims
- 1187US10060909B2Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereofSENOMYX INC·Filed 2014·Granted Aug 28, 2018·2 cites·31 claims
- 1285US10557845B2Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereofFIRMENICH INCORPORATED·Filed 2018·Granted Feb 11, 2020·1 cites·19 claims
- 1385US7683057B2Kinase inhibitor compoundsTYROGENEX INC·Filed 2007·Granted Mar 23, 2010·8 cites·22 claims
- 1483US11031606B2Reversible bifunctional air electrode catalyst for rechargeable metal air battery and regenerative fuel cellUNIV TENNESSEE RES FOUND·Filed 2019·Granted Jun 8, 2021·1 cites·10 claims
- 1581US2022326230A1Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereofFIRMENICH INCORPORATED·Filed 2022·Application pending·0 cites
- 1675US11268952B2Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereofFIRMENICH INCORPORATED·Filed 2020·Granted Mar 8, 2022·0 cites·20 claims
- 1774USD1046614SOral care package with surface ornamentationPROCTER & GAMBLE·Filed 2021·Granted Oct 15, 2024·4 cites·1 claims
- 1874US11978207B2Oral care based digital imaging systems and methods for determining perceived attractiveness of a facial image portionPROCTER & GAMBLE·Filed 2021·Granted May 7, 2024·1 cites·23 claims
- 1974US10522842B2Reversible bifunctional air electrode catalyst for rechargeable metal air battery and regenerative fuel cellUNIV TENNESSEE RES FOUND·Filed 2014·Granted Dec 31, 2019·1 cites·9 claims
- 2068US2023348615A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their UsesJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 2168US2023340145A1Methods of Treating High Risk Multiple MyelomaJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 2267US2025043437A1Two-phase solutions for electrochemically generating chemical productsPHASE TWO CHEMICALS INC·Filed 2023·Application pending·0 cites
- 2367US2025043447A1Articles, systems, and methods for electrochemically generating chemical productsPHASE TWO CHEMICALS INC·Filed 2023·Application pending·0 cites
- 2464US2023233676A1Use of Approved Anti-CD38 Antibody Drug Product in Combination with Pomalidomide and Dexamethasone to Treat Multiple MyelomaJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 2562US2023295333A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and DexamethasoneJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 2662US2023250174A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Lenalidomide and DexamethasoneJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 2762US2023136301A1Corticosteriod Reduction in Treatment with Anti-CD38 AntibodyJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2862US2023277660A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and PrednisoneJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 2962US2023330224A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and DexamethasoneJANSSEN BIOTECH INC·Filed 2023·Application pending·0 cites
- 3062US2023134748A1Corticosteriod Reduction in Treatment with Anti-CD38 AntibodyJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 3161US12340510B2Oral care based digital imaging systems and methods for analyzing attributes of a facial image portionPROCTER & GAMBLE·Filed 2023·Granted Jun 24, 2025·0 cites·19 claims
- 3260US2022041745A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their UsesJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 3359US12053788B2Pump dispenser systemPROCTER & GAMBLE·Filed 2022·Granted Aug 6, 2024·0 cites·16 claims
- 3457US2021393775A1Daratumumab and Hyaluronidase for the Treatment of Multiple MyelomaJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 3555US2006045953A1Aromatic amides and ureas and their uses as sweet and/or umami flavor modifiers, tastants and taste enhancersTACHDJIAN CATHERINE·Filed 2005·Application pending·0 cites
- 3654US2020308297A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their UsesJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 3753US2011224212A1Kinase inhibitor compoundsTYROGENEX INC·Filed 2011·Application pending·0 cites
- 3852US11289875B2Temperature control device with a plurality of electrically conductive terminals, and an optical subassembly module implementing sameAPPLIED OPTOELECTRONICS INC·Filed 2019·Granted Mar 29, 2022·0 cites·18 claims
- 3952US2020316197A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib and DexamethasoneJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 4052US2020268847A1Methods of Treating Newly Diagnosed Multiple Myeloma with a Combination of An Antibody that Specifically Binds CD38, Lenalidomide and DexamethasoneJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 4151US2021290553A1Hc-1119 formulation, preparation method and use thereofHINOVA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4249US9467224B2Method and device for determining input optical powerHUAWEI TECH CO LTD·Filed 2014·Granted Oct 11, 2016·0 cites·8 claims
- 4349US2020308284A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Lenalidomide and DexamethasoneJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 4449US2020330593A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Bortezomib, Mephalan and PrednisoneJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 4549US2020308296A1Clinically Proven Subcutaneous Pharmaceutical Compositions Comprising Anti-CD38 Antibodies and Their Uses in Combination with Pomalidomide and DexamethasoneJANSSEN BIOTECH INC·Filed 2020·Application pending·0 cites
- 4648US2021122535A1Dispenser For Oral Care CompositionPROCTER & GAMBLE·Filed 2020·Application pending·0 cites
- 4748US2019144155A1Finger tabPROCTER & GAMBLE·Filed 2018·Application pending·0 cites
- 4845US2018170646A1Oral care article comprising a containerPROCTER & GAMBLE·Filed 2017·Application pending·0 cites
- 4943US11232364B2Automated rule recommendation engineDATAVISOR INC·Filed 2018·Granted Jan 25, 2022·0 cites·19 claims
- 5038US2003089885A1Use of low molecular weight acetal, alcohol, acylated alcohol and ester compounds to block or reduce odor of carboxylic acidsSENOMYX INC·Filed 2002·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ming Qi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →